Company Filing History:
1 out of 4 
1 out of 5 Years Active: 2020
Title: Agnieszka Szamborska-Gbur: Innovator in Pharmaceutical Chemistry
Introduction
Agnieszka Szamborska-Gbur is a prominent inventor based in Tenczynek, Poland. With a strong background in pharmaceutical chemistry, she has made significant contributions to the field, particularly in the development of innovative compounds aimed at treating various medical conditions.
Latest Patents
Agnieszka holds one patent related to her research on quinoline derivatives. Her patent, titled "Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases," encompasses a compound of a specific formula along with its salts, stereoisomers, tautomers, and N-oxides. This invention is particularly valuable as it relates to the use of the compound or its derivatives as a medicament, along with a pharmaceutical composition comprising the innovative compound.
Career Highlights
Throughout her career, Agnieszka has been affiliated with several notable organizations where she has honed her expertise in pharmaceutical research. She has worked with Felicitex Therapeutics, Inc., and Selvita S.A., contributing to various projects aimed at advancing medicinal chemistry.
Collaborations
Agnieszka has collaborated with esteemed professionals in her field, including her coworkers Agnieszka Dreas and Charles-Henry Fabritius. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality and impact of her work.
Conclusion
Agnieszka Szamborska-Gbur represents the innovative spirit of modern pharmaceutical research. Her patent addressing the inhibitors of distinct kinases exemplifies her commitment to advancing medical treatments through her inventions. With a solid career foundation and valuable collaborations, Agnieszka continues to contribute significantly to her field.